You are here

  • Home
  • Archive
  • Volume 89, Issue 4
  • A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)

Article metrics

Article menu

Download PDFPDF

Multiple sclerosis
Research paper
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
Free

 

Online download statistics by month:

Online download statistics by month: December 2017 to February 2023

AbstractFullPdf
Dec 2017190110339
Jan 201838121147199
Feb 20186543517
Mar 2018126214362
Apr 201880311847
May 20187013831
Jun 20183772916
Jul 2018986168
Aug 20182551410
Sep 201819284
Oct 20182571312
Nov 2018268128
Dec 20183822312
Jan 20193153015
Feb 20191573222
Mar 201916115740
Apr 201911010119
May 201912711618
Jun 201914914628
Jul 201917216131
Aug 201957857229
Sep 201915214642
Oct 201919318826
Nov 201919018038
Dec 201917416817
Jan 202020820331
Feb 202013813721
Mar 202017016825
Apr 202013813629
May 202016416332
Jun 202014114026
Jul 202011510828
Aug 202011110625
Sep 202014812420
Oct 202012213216
Nov 202011110133
Dec 202045845146
Jan 202145644948
Feb 202120520142
Mar 202119218330
Apr 202126726631
May 202135134332
Jun 202131931518
Jul 202120920721
Aug 202122221825
Sep 202122822526
Oct 202123423339
Nov 202117216328
Dec 202141640978
Jan 202242743454
Feb 202224424925
Mar 202227227228
Apr 202223623229
May 202222221146
Jun 202222722518
Jul 202217117023
Aug 202224023416
Sep 202243441862
Oct 202249247026
Nov 202231030835
Dec 202219219120
Jan 202323323224
Feb 202324324723
Total23566127701969